Chronic Pelvic Pain Clinical Trial
Official title:
A Pilot Study to Assess the Feasibility of a Randomized Control Trial Employing a Single-arm Intervention, at a Single Institution, to Study the Effects of Combined Self-induced Therapeutic Tremors Plus Mindfulness on Symptoms of Chronic Pelvic Pain.
NCT number | NCT05467241 |
Other study ID # | 4818 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 12, 2021 |
Est. completion date | May 30, 2022 |
Verified date | July 2022 |
Source | University of Tennessee Graduate School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To collect pilot data and assess the feasibility of a trial employing a single-arm intervention to study the effects of combined self-induced therapeutic tremors plus mindfulness on symptoms of chronic pelvic pain among women diagnosed with chronic pelvic pain.
Status | Completed |
Enrollment | 10 |
Est. completion date | May 30, 2022 |
Est. primary completion date | April 29, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Women - Age >18 - Physical requirements: be able to complete the intervention sessions - Not seeking other therapeutic modalities, such as acupuncture, PT, during study duration - Free from surgery for >3 months - being treated clinically for chronic pelvic pain and related conditions - CPP of 6 months or more (to be considered chronic) - Availability to commit to the 4-week intervention (two 60-minute sessions per week at a specified time, for 4 weeks) - Internet access and consistent access to phone/email/text communication Exclusion Criteria: - Pregnancy - Illicit substance use (e.g. cocaine, methamphetamines, heroin, street drugs) - marijuana and CBD oil and related supplements will be considered on a case-by-case basis by the principal investigators - Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principal investigators |
Country | Name | City | State |
---|---|---|---|
United States | The University of Tennessee Graduate School of Medicine | Knoxville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
University of Tennessee Graduate School of Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of the pilot trial | To determine feasibility, the investigators will assess if it is possible to recruit, enroll, and have complete follow-up with participants. If the recruitment goal is met and 80% compliance with study visit attendance is achieved, the trial will be classified as feasible (yes/no classification). | This will be assessed at the completion of the study, approximately 1-1.5 years after the study start. | |
Secondary | Change in Physical Function | PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Physical Function. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a better outcome.
The change in T-score for this domain, across time, is assessed using repeated measures ANOVA. |
Pre- Program, Immediately Post-Program, and 1 Month Follow Up | |
Secondary | Change in Anxiety | PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Anxiety. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.
The change in T-score for this domain, across time, is assessed using repeated measures ANOVA. |
Pre- Program, Immediately Post-Program, and 1 Month Follow Up | |
Secondary | Change in Depression | PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Depression. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.
The change in T-score for this domain, across time, is assessed using repeated measures ANOVA. |
Pre- Program, Immediately Post-Program, and 1 Month Follow Up | |
Secondary | Change in Fatigue | PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Fatigue. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.
The change in T-score for this domain, across time, is assessed using repeated measures ANOVA. |
Pre- Program, Immediately Post-Program, and 1 Month Follow Up | |
Secondary | Change in Sleep Disturbance | PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Sleep Disturbance. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.
The change in T-score for this domain, across time, is assessed using repeated measures ANOVA. |
Pre- Program, Immediately Post-Program, and 1 Month Follow Up | |
Secondary | Change in Ability to Participant in Social Roles and Activities | PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Ability to Participate in Social Roles and Activities. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a better outcome.
The change in T-score for this domain, across time, is assessed using repeated measures ANOVA. |
Pre- Program, Immediately Post-Program, and 1 Month Follow Up | |
Secondary | Change in Pain Intensity | PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Pain Intensity. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.
The change in T-score for this domain, across time, is assessed using repeated measures ANOVA. |
Pre- Program, Immediately Post-Program, and 1 Month Follow Up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03638856 -
Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
|
N/A | |
Withdrawn |
NCT03272360 -
Endometriosis Biomarker Discovery Study
|
N/A | |
Completed |
NCT01020162 -
Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT05836454 -
The Soft Tissue Mobilization Techniques on PMS
|
N/A | |
Completed |
NCT02372903 -
Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis
|
N/A | |
Recruiting |
NCT05185180 -
Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
|
||
Recruiting |
NCT05970783 -
A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
|
Phase 3 | |
Completed |
NCT04615247 -
Program to Overcome Pelvic Pain Study
|
N/A | |
Completed |
NCT02721108 -
Mindfulness Meditation for Chronic Pelvic Pain Management
|
N/A | |
Not yet recruiting |
NCT00844012 -
Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain
|
Phase 4 | |
Recruiting |
NCT04976751 -
Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China
|
Phase 1 | |
Withdrawn |
NCT04252040 -
Open Label Extension Study of tDCS Plus Guided Imagery for Women With Chronic Pelvic Pain (CPP)
|
N/A | |
Completed |
NCT01802528 -
Clinical Effectiveness of Obturator Externus Muscle Injection in Chronic Pelvic Pain Patients
|
N/A | |
Completed |
NCT03175809 -
Pelvic Floor Muscles Training Associated Dry Needling for Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT05324280 -
Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain
|
N/A | |
Not yet recruiting |
NCT02556411 -
Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)
|
N/A | |
Completed |
NCT04104542 -
MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women
|
N/A | |
Completed |
NCT01553201 -
Botulinum Toxin for Pelvic Pain in Women With Endometriosis
|
Phase 1/Phase 2 | |
Completed |
NCT03617627 -
Self-management Program in Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT06019091 -
Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Pelvic Pain in Adults
|
N/A |